Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies

Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies

Effectiveness of levetiracetam (LEV) in treatment of typical benign rolandic epilepsy and variants of benign idiopathic focal epilepsies was studied in 32 children (mean age 10.6 years, range 4-14) by researchers at Epilepsy Centre for Children and Young People, Vogtareuth, Germany.

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 2010-03-01
Series:Pediatric Neurology Briefs
Subjects:
levetiracetam
benign idiopathic focal epileptiform discharges
epileptiform discharges
Online Access:https://www.pediatricneurologybriefs.com/articles/806
id doaj-efea14ef3c484554a606f0ea88997d0e
record_format Article
spelling doaj-efea14ef3c484554a606f0ea88997d0e2020-11-25T03:09:21ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64822010-03-01243202110.15844/pedneurbriefs-24-3-5792Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal EpilepsiesJ Gordon Millichap0Northwestern University Feinberg School of MedicineEffectiveness of levetiracetam (LEV) in treatment of typical benign rolandic epilepsy and variants of benign idiopathic focal epilepsies was studied in 32 children (mean age 10.6 years, range 4-14) by researchers at Epilepsy Centre for Children and Young People, Vogtareuth, Germany.https://www.pediatricneurologybriefs.com/articles/806levetiracetambenign idiopathic focal epileptiform dischargesepileptiform discharges
collection DOAJ
language English
format Article
sources DOAJ
author J Gordon Millichap
spellingShingle J Gordon Millichap
Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
Pediatric Neurology Briefs
levetiracetam
benign idiopathic focal epileptiform discharges
epileptiform discharges
author_facet J Gordon Millichap
author_sort J Gordon Millichap
title Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
title_short Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
title_full Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
title_fullStr Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
title_full_unstemmed Levetiracetam Add-On Therapy for Rolandic and Other Benign Idiopathic Focal Epilepsies
title_sort levetiracetam add-on therapy for rolandic and other benign idiopathic focal epilepsies
publisher Pediatric Neurology Briefs Publishers
series Pediatric Neurology Briefs
issn 1043-3155
2166-6482
publishDate 2010-03-01
description Effectiveness of levetiracetam (LEV) in treatment of typical benign rolandic epilepsy and variants of benign idiopathic focal epilepsies was studied in 32 children (mean age 10.6 years, range 4-14) by researchers at Epilepsy Centre for Children and Young People, Vogtareuth, Germany.
topic levetiracetam
benign idiopathic focal epileptiform discharges
epileptiform discharges
url https://www.pediatricneurologybriefs.com/articles/806
work_keys_str_mv AT jgordonmillichap levetiracetamaddontherapyforrolandicandotherbenignidiopathicfocalepilepsies
_version_ 1724663157024096256

Similar Items